Massolt Elske T, Salih Mahdi, Beukhof Carolien M, Kam Boen L R, Burger J W, Visser W Edward, Hoorn Ewout J, Peeters Robin P
Division of Endocrinology, Erasmus MC, Rotterdam, The Netherlands.
Rotterdam Thyroid Center, Department of Internal Medicine, Erasmus MC, Rotterdam, The Netherlands.
Eur Thyroid J. 2017 Sep;6(5):238-242. doi: 10.1159/000478521. Epub 2017 Jul 3.
Hypothyroidism has been associated with impaired urinary concentrating ability. However, previous reports on thyroid hormone and urinary concentrating ability in humans only studied a limited number of patients with autoimmune thyroid disease or used healthy controls instead of paired analysis within the same patients.
To study the urinary concentrating ability in athyreotic patients with differentiated thyroid cancer on and off levothyroxine treatment as they are exposed to different thyroid states as part of their treatment in the absence of an autoimmune disease.
We studied 9 patients (mean age of 42.7 years) during severe hypothyroid state (withdrawal of levothyroxine before radioactive iodine therapy) and TSH-suppressed state (on levothyroxine therapy). At these two points, serum and urine samples were collected after 14 h of overnight fasting without any food or drink.
Serum and urine osmolality were not significantly different between on and off levothyroxine treatment. Serum creatinine levels were significantly higher in patients off versus on levothyroxine treatment (87.0 vs. 71.0 µmol/L, respectively; = 0.044) and, correspondingly, the estimated glomerular filtration rate was significantly lower (89.6 vs. 93.1 mL/min, respectively; = 0.038).
Short-term, severe hypothyroidism has no effect on urinary concentrating ability. Our study confirms the well-known effects of thyroid hormone on serum creatinine concentrations.
甲状腺功能减退与尿浓缩能力受损有关。然而,先前关于人类甲状腺激素与尿浓缩能力的报告仅研究了少数自身免疫性甲状腺疾病患者,或使用健康对照而非对同一患者进行配对分析。
研究分化型甲状腺癌无甲状腺患者在左甲状腺素治疗期间及停药时的尿浓缩能力,因为在无自身免疫性疾病的情况下,他们在治疗过程中会经历不同的甲状腺状态。
我们研究了9名患者(平均年龄42.7岁),分别处于严重甲状腺功能减退状态(放射性碘治疗前停用左甲状腺素)和促甲状腺激素抑制状态(接受左甲状腺素治疗)。在这两个时间点,过夜禁食14小时且未进食或饮水后采集血清和尿液样本。
左甲状腺素治疗期间及停药时,血清和尿渗透压无显著差异。停药患者的血清肌酐水平显著高于用药患者(分别为87.0和71.0µmol/L;P = 0.044),相应地,估计肾小球滤过率显著更低(分别为89.6和93.1 mL/min;P = 0.038)。
短期、严重的甲状腺功能减退对尿浓缩能力无影响。我们的研究证实了甲状腺激素对血清肌酐浓度的已知影响。